Samil Pharmaceutical Co.,Ltd (KRX:000520)
South Korea · Delayed Price · Currency is KRW
11,290
+200 (1.80%)
At close: Feb 20, 2026
Revenue by Segment
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 |
|---|
| 219.70B | 196.35B | 179.68B | 134.25B | 123.00B | | | | | |
| 11.89% | 9.28% | 33.84% | 9.14% | 1.56% | | | | | |
| 219.70B | 196.35B | 179.68B | 134.25B | 123.00B | | | | | |
| 11.89% | 9.28% | 33.84% | 9.14% | 1.56% | | | | | |
Revenue by Geography
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 |
|---|
| 217.52B | 194.93B | 178.83B | 133.73B | 121.26B | | | | | |
| 11.59% | 9.00% | 33.72% | 10.28% | 0.92% | | | | | |
| 2.18B | 1.42B | 842.66M | 514.49M | 1.73B | | | | | |
| 53.48% | 68.47% | 63.78% | -70.33% | 84.01% | | | | | |
| 219.70B | 196.35B | 179.68B | 134.25B | 123.00B | | | | | |
| 11.89% | 9.28% | 33.84% | 9.14% | 1.56% | | | | | |
Source: S&P Global Market Intelligence.